What's in Grifols Biologicals, LLC's pipeline?

Grifols Biologicals, LLC has 4 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Grifols Biologicals, LLC's portfolio?

Top competitors by shared drug class: Baxalta now part of Shire, Baxter Healthcare Corporation, Bio Products Laboratory, Biotest, CSL Behring.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/grifols-biologicals-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Grifols Biologicals, LLC — Portfolio Competitive Intelligence Brief

Grifols Biologicals, LLC pipeline: 1 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Alphanate SD/HT	Alphanate SD/HT	marketed	Clotting factor concentrate; Factor VIII replacement therapy	Factor VIII (antihemophilic factor)	Hematology
Fibrin Sealant (FS) Grifols	Fibrin Sealant (FS) Grifols	phase 3	Hemostatic agent / Fibrin sealant	Fibrinogen (substrate for thrombin-mediated polymerization)	Surgery / Hemostasis
IGIV3I Grifols 10%	IGIV3I Grifols 10%	phase 3	Intravenous immunoglobulin (IVIG)		Immunology

Therapeutic area mix

Hematology · 1
Immunology · 1
Surgery / Hemostasis · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Baxalta now part of Shire · 1 shared drug class
Baxter Healthcare Corporation · 1 shared drug class
Bio Products Laboratory · 1 shared drug class
Biotest · 1 shared drug class
CSL Behring · 1 shared drug class
CSL Limited · 1 shared drug class
Ethicon, Inc. · 1 shared drug class
ADMA Biologics, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Grifols Biologicals, LLC:

Cite this brief

Drug Landscape (2026). Grifols Biologicals, LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/grifols-biologicals-llc. Accessed 2026-05-16.